Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-17T18:51:40.315Z Has data issue: false hasContentIssue false

Effects of moderate increases in dietary polyunsaturated: saturated fat on plasma triglyceride and cholesterol levels in man

Published online by Cambridge University Press:  24 July 2007

Fredric B. Kraemer
Affiliation:
Department of Medicine, Stanford University School of Medicine and Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center (182 B), Palo Alto, California 94304
Michael Greenfield
Affiliation:
Department of Medicine, Stanford University School of Medicine and Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center (182 B), Palo Alto, California 94304
Ted A. Tobey
Affiliation:
Department of Medicine, Stanford University School of Medicine and Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center (182 B), Palo Alto, California 94304
Gerald M. Reaven
Affiliation:
Department of Medicine, Stanford University School of Medicine and Geriatric Research, Education and Clinical Center, Veterans Administration Medical Center (182 B), Palo Alto, California 94304
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. The effects of two isoenergetic diets differing only in the values for polyunsaturated: saturated fat (P : S values of 0·2 v. 2·0) were studied in twenty adult human volunteers.

2. A period of 14 d on the high P:S diet failed to produce significant changes in fasting triglyceride levels, though there were individual variations. On the other hand, fasting cholesterol levels dropped by 10% (P < 0.005). High-density-lipoprotein-cholesterol concentrations were not influenced by changes in the P:S value.

3. Investigations into the mechanism by which changes in the P:S value might affect plasma triglyceride values revealed no consistent effects on very-low-density-lipoprotein kinetics, insulin secretion, insulin sensitivity or free fatty acid concentrations.

4. The results of this study suggest that the largest increase in dietary P:S values that is likely to be obtained on a long-term basis may have only a small effect on plasma triglyceride and cholesterol concentration.

Type
Papers of direct reference to Clinical and Human Nutrition
Copyright
Copyright © The Nutrition Society 1982

References

Ahrens, E. H. Jr., Hirsch, J., Insull, W., Tsaltas, T. T., Blomstrand, R. & Peterson, M. L. (1957). Lancet i, 943.Google Scholar
Akio, N., Hiroak, O. & Kitta, M. (1973). Clinica chem. Acta 43, 317.Google Scholar
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W. & Fu, P. C. (1975). Clin. chem. 20, 470.Google Scholar
Antonis, A. & Bersohn, I. (1961). Lancet i, 3.Google Scholar
Bernstein, M., Scholnick, A. R. & Morpa, R. (1970). J. Lipid Res. 11, 583.Google Scholar
Bronte-Stewart, B., Kirp, A., Brock, J. F., Moodie, A. D., Kirp, M. H. & Antonis, A. (1955). Lancet ii, 1103.Google Scholar
Carlson, L. A. & Bottiger, L. E. (1972). Lancet i, 865.Google Scholar
Carroll, K. K. (1978). Nutr. Rev. 35, 1.Google Scholar
Chait, A., Onitin, A., Nicoll, A., Rabaya, E., Davier, J. & Lewis, B. (1974). Atherosclerosis 20, 347.Google Scholar
Conner, W. E., Witich, D. T., Stone, D. B. & Armstrong, M. L. (1975). J. clin. Invest. 48, 1363.Google Scholar
Desbuquois, B. & Aurbach, G. D. (1971). J. clin. Endocr. Metab. 33, 732.Google Scholar
Durrington, P. N., Bolton, C. H., Hartog, M., Angelinetta, R., Emmett, P. & Furniss, S. (1977). Atherosclerosis 27, 465.Google Scholar
Engelberg, H. (1966). Metabolism 15, 796.Google Scholar
Farquhar, J., Gross, R., Wagner, R. M. & Reaven, G. M. (1965). J. Lipid Res. 6, 119.Google Scholar
Goldstein, J. L., Hazzard, W. R., Schrott, T. G., Bierman, E. L. & Motulsky, A. G. (1973). J. clin. Invest. 52, 1533.Google Scholar
Grundy, S. M. (1975). J. clin. Invest. 55, 269.Google Scholar
Hall, T., Stamler, J., Cohen, D. B., Mojonnier, L., Epstein, M. B., Berkson, D. M., Whipple, I. T. & Catchings, S. (1972). Atherosclerosis 16, 389.Google Scholar
Kannel, W. B., Castelli, W. P., Gordon, T. & McNamara, P. M. (1971). Ann. int. Med. 74, 1.Google Scholar
Kessler, G. & Lederer, H. (1976). In Automation in Analytical Chemistry, p. 341 [Skaggs, L. T. editor]. New York, NY: Med. Incorp.Google Scholar
Kinsell, L. W., Michaelis, G. D., Partridge, J. W., Boling, C. A., Balch, H. E. & Cochrane, G. C. (1953). J. clin. Nutr. 1, 224.Google Scholar
Kinsell, L. W., Partridge, J., Boling, C., Margen, S. & Michaelis, G. (1952). J. clin. Endocr. Metab. 12, 909.Google Scholar
Kritchevsky, D. (1976). Am. J. Pathol. 84, 615.Google Scholar
Metropolitan Life Insurance Co. (1959). Statistical Bulletin 40, 1.Google Scholar
Nestel, P. J., Carroll, K. F. & Haverstein, J. (1970). Metabolism 19, 1.Google Scholar
Olefsky, J. M., Farquhar, J. W. & Reaven, G. M. (1974). Am. J. Med. 57, 551.Google Scholar
Olefsky, J. M., Reaven, G. M. & Farquhar, J. W. (1974). J. clin. Invest. 53, 64.CrossRefGoogle Scholar
Reaven, G., Hill, D., Gross, R. & Farquhar, J. W. (1965). J. clin. Invest. 44, 1826.Google Scholar
Shen, S. W., Reaven, G. & Farquhar, J. W. (1970). J. clin. Invest. 48, 2151.Google Scholar
Shephard, J., Packard, C. J., Grundy, S. M., Yeshurun, D., Gotto, A. M. Jr. & Taunton, O. D. (1980). J. Lipid Res. 21, 91.Google Scholar
Shephard, J., Packard, C. J., Patsch, J. R., Gotto, A. M. Jr. & Taunton, O. D. (1978). J. clin. Invest. 61, 1582.Google Scholar
Spritz, N. & Mishkel, M. A. (1969). J. clin. Invest. 48, 78.Google Scholar
Vessby, B., Gustafsson, I.-B., Boberg, J., Karlstrom, B., Lithell, H. & Werner, I. (1980). Eur. J. clin. Invest. 10, 193.Google Scholar
Wilson, W. S., Hulley, S. B., Burrows, M. I. & Nickaman, M. Z. (1971). Am. J. Med. 51, 491.Google Scholar